ReviewDiscover artificial intelligence2025
A review of machine learning and deep learning for Parkinson's disease detection.
Review in Discover artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Current Trends in AI Gait Analysis for the Detection and Assessment of Parkinson's Disease Severity: Systematic Review and Meta-Analysis of Performance Using Logit Transformation.Healthcare (Basel, Switzerland) · 2026Review
- Clinically Deployable Handwriting Biomarkers of Parkinson's Disease via Multiscale Attention and Bayesian-Genetic Optimization.Brain and behavior · 2026Article
- Digital Gait Biomarkers for Parkinson's Disease: Subject-Wise Validated Explainable AI Framework Using Vertical Ground Reaction Force Signals.Bioengineering (Basel, Switzerland) · 2026Article
- Volumetric signatures of basal ganglia-thalamo-cortical and cerebello-thalamo-cortical networks in Parkinson's disease and its motor subtypes.Frontiers in aging neuroscience · 2026Article
- From Pixels to Predictions: Integrating Machine Learning and Digital Image Correlation for Damage Identification in Engineering Materials.Materials (Basel, Switzerland) · 2025Review
- Voice-Based Detection of Parkinson's Disease Using Machine and Deep Learning Approaches: A Systematic Review.Bioengineering (Basel, Switzerland) · 2025Review
- A swarm intelligence-driven hybrid framework for brain tumor classification with enhanced deep features.Scientific reports · 2025Article
- Gut Microbiome as a Source of Probiotic Drugs for Parkinson's Disease.International journal of molecular sciences · 2025Review
- The Effect of Data Leakage and Feature Selection on Machine Learning Performance for Early Parkinson's Disease Detection.Bioengineering (Basel, Switzerland) · 2025Article
- Redefining Non-Motor Symptoms in Parkinson's Disease.Journal of personalized medicine · 2025Review
- Explainable machine learning for early detection of Parkinson's disease in aging populations using vocal biomarkers.Frontiers in aging neuroscience · 2025Article
- Article
- EEFSA-SECM: an enhanced ensemble feature selection and stacking ensemble classifier to detect Parkinson's disease.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Millions of people worldwide suffer from Parkinson's disease (PD), a neurodegenerative disorder marked by motor symptoms such as tremors, bradykinesia, and stiffness. Accurate early diagnosis is crucial for effective management and treatment. This article presents a novel review of Machine Learning (ML) and Deep Learning (DL) techniques for PD detection and progression monitoring, offering new perspectives by integrating diverse data sources. We examine the public datasets recently used in studies, including audio recordings, gait analysis, and medical imaging. We discuss the preprocessing methods applied, the state-of-the-art models utilized, and their performance. Our evaluation included different algorithms such as support vector machines (SVM), random forests (RF), convolutional neural networks (CNN). These algorithms have shown promising results in PD diagnosis with accuracy rates exceeding 99% in some studies combining data sources. Our analysis particularly showcases the effectiveness of audio analysis in early symptom detection and gait analysis, including the Unified Parkinson's Disease Rating Scale (UPDRS), in monitoring disease progression. Medical imaging, enhanced by DL techniques, has improved the identification of PD. The application of ML and DL in PD research offers significant potential for improving diagnostic accuracy. However, challenges like the need for large and diverse datasets, data privacy concerns, and data quality in healthcare remain. Additionally, developing explainable AI is crucial to ensure that clinicians can trust and understand ML and DL models. Our review highlights these key challenges that must be addressed to enhance the robustness and applicability of AI models in PD diagnosis, setting the groundwork for future research to overcome these obstacles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.